Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Effect of Olanzapine in Cancer Pain: A Double-Blind Randomized Placebo-Controlled Parallel Group Pilot Study

NCT00737191 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00737191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00737191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Effect of Olanzapine in Cancer Pain: A Double-Blind Randomized Placebo-Controlled Parallel Group Pilot Study
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2008
Completion date
November 30, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic/lymphoid cancer, pain, unspecified adult solid tumor, protocol specific